A 28-year-old man with schizophrenia has persistent negative symptoms, flat affect, social withdrawal, and avolition, despite adequate trials of two second-generation antipsychotics. The PMHNP reviews the glutamate hypothesis of schizophrenia to understand why dopamine-focused treatments may be insufficient for negative symptoms. Which of the following best describes the glutamate hypothesis and its clinical implications?